Aptevo Therapeutics to Present at the 29th Annual ROTH Conference
07 March 2017 - 12:30AM
Aptevo Therapeutics Inc. (Nasdaq:APVO), a biotechnology company
focused on developing novel oncology and hematology therapeutics,
today announced that management will be presenting at the 29th
Annual ROTH Conference on Wednesday, March 15, 2017 at 10:30 AM PT
at the Ritz Carlton, Laguna Niguel, California.
A live audio webcast of the presentation can be
accessed at www.aptevotherapeutics.com under the ‘Investors’
section of the website, under ‘Events.’ An audio reply of the
webcast will be available following the live webcast.
About Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc. is a biotechnology company
focused on novel oncology and hematology therapeutics to
meaningfully improve patients’ lives. Our core technology is the
ADAPTIR™ (modular protein technology) platform. Aptevo has four
commercial products in the areas of hematology and infectious
diseases, as well as various investigational stage product
candidates in immuno-oncology.
Stacey Jurchison
Senior Director, Investor Relations and Corporate Communications
206-859-6628
JurchisonS@apvo.com
Aptevo Therapeutics (NASDAQ:APVO)
Historical Stock Chart
From Apr 2024 to May 2024
Aptevo Therapeutics (NASDAQ:APVO)
Historical Stock Chart
From May 2023 to May 2024